Skip to main content
Clinical Trials/ITMCTR2000003429
ITMCTR2000003429
Not yet recruiting
Phase 1

A randomized controlled study on the treatment of primary dysmenorrhea with heat burning blood stasis by Guizhi Fuling Wan

Yichang Second People's Hospital0 sitesTBD

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
Not specified
Sponsor
Yichang Second People's Hospital
Status
Not yet recruiting
Last Updated
3 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
3 years ago
Study Type
Interventional study
Sex
Female

Investigators

Sponsor
Yichang Second People's Hospital

Eligibility Criteria

Inclusion Criteria

  • Those who meet the following 7 items can be included in the study. If there is any inconformity, the patient cannot enter the study
  • 1\. Patients aged 16\-30 years;
  • 2\. To diagnose patients with primary dysmenorrhea according to the consensus guideline of primary dysmenorrhea;
  • 3\. No parturient;
  • 4\. Self described pain duration: from 6 months to 15 years;
  • 5\. Patients with an average pain intensity of 40 or more (VAS by 100 mm visual analogue scale) and at least three consecutive menstrual cycles;
  • 6\. Patients with syndrome of heat burning and blood stasis;
  • 7\. The informed consent shall be signed by the patient himself or by his immediate relatives.

Exclusion Criteria

  • Patients cannot enter the study if any of the following are met:
  • 1\. Patients who can not complete the treatment plan of this study within half a year;
  • 2\. Patients with secondary dysmenorrhea (such as endometriosis or adenomyosis);
  • 3\. Patients with irregular menstrual cycle (beyond the typical range of 21\-35 days);
  • 4\. Women with pregnancy plan in the past half year;
  • 5\. Patients with mental disorders and mental disorders who can not cooperate with the questionnaire survey;
  • 6\. Patients with serious cardiovascular disease, liver and kidney function damage, psychological disease or life\-threatening situation;
  • 7\. Patients who are using analgesics;
  • 8\. Patients who have participated in or are participating in other clinical trials.

Outcomes

Primary Outcomes

Not specified

Similar Trials